Figure 5From: Treatment patterns in psoriatic arthritis patients newly initiated on oral nonbiologic or biologic disease-modifying antirheumatic drugsPatients remaining on any PsA-related therapy by month. In this figure, only nonbiologic DMARDs and biologic DMARDs are considered as any PsA-related therapy. DMARD, disease-modifying antirheumatic drug; MTX, methotrexate; PsA, psoriatic arthritis.Back to article page